Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia. [electronic resource]
Producer: 20190610Description: 30 p. digitalISSN:- 1559-131X
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Everolimus -- administration & dosage
- Humans
- Imatinib Mesylate -- administration & dosage
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.